Sixth Street Partners Management Company »

Miragen Therapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 815k 18.37

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Kynam Capital Management
Fairmount Funds Management
State Street Corporation
Vanguard Capital Management
Deep Track Capital
VR Adviser
T. Rowe Price Associates
Wellington Management Company
Vanguard Portfolio Management
Geode Capital Management
venBio Select Advisor

View all funds holding Miragen Therapeutics